263 filings
Page 7 of 14
6-K
dwwj6t69t34zp
27 Aug 19
ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million
9:36pm
6-K
i6wvjqb28t952
23 Aug 19
ESSA PHARMA announces $36 Million public offering of common stock and concurrent private placement
11:56am
6-K
wknv18g1442k9177m0
14 Aug 19
Current report (foreign)
12:00am
6-K
xf0 fcvz61rjvc9uwk2v
31 Jul 19
ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective
8:39am
6-K
4an6h 92jdo
30 Jul 19
ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics
8:51am
6-K
vlxbj
15 Jul 19
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
9:10am
6-K
v5ksx2
8 Jul 19
ESSA Provides Update on Court Hearing
4:37pm
6-K
t7uiaiuuxvo9uqua
27 Jun 19
ESSA Provides an Update to the Acquisition of Realm Therapeutics
12:00am
6-K
uughqx7w1baswyfc6xn
26 Jun 19
ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders
9:34am
6-K
71uw muqrlmfdq7j
21 Jun 19
ESSA Pharma to Hold Annual Shareholders' Meeting and Announces Three Realm-Nominated Directors
9:18pm
6-K
vomthtoxa
24 May 19
Material Change Report
8:42pm
6-K
np1iazbcon jw3yx8
16 May 19
Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics
10:05am
6-K
dbc5ri ln
10 May 19
Current report (foreign)
8:00am
6-K
7mmnyfs
6 May 19
Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting
8:12am
6-K
9joefp hpesd
25 Apr 19
ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019
10:02am
6-K
flbyoc1tddkri5ut
17 Apr 19
ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting
8:59am
6-K
d0yk twdjb
12 Apr 19
Current report (foreign)
7:47am
6-K
jxzk611dwjvaq32
28 Mar 19
ESSA Pharma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019
5:26pm
6-K
g7hsea3 0zw6
28 Mar 19
ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer
5:17pm
6-K
rzwslk
18 Mar 19
ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference
8:43am